Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Assets Average (2018 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Assets Average for 8 consecutive years, with $134.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average fell 30.88% year-over-year to $134.4 million, compared with a TTM value of $134.4 million through Sep 2025, down 30.88%, and an annual FY2024 reading of $146.9 million, down 3.02% over the prior year.
  • Assets Average was $134.4 million for Q3 2025 at X4 Pharmaceuticals, up from $117.6 million in the prior quarter.
  • Across five years, Assets Average topped out at $194.4 million in Q3 2024 and bottomed at $90.3 million in Q2 2022.
  • Average Assets Average over 5 years is $138.6 million, with a median of $138.2 million recorded in 2025.
  • The sharpest move saw Assets Average plummeted 40.32% in 2022, then soared 78.32% in 2023.
  • Year by year, Assets Average stood at $118.8 million in 2021, then increased by 13.17% to $134.5 million in 2022, then grew by 19.17% to $160.3 million in 2023, then increased by 1.27% to $162.3 million in 2024, then decreased by 17.22% to $134.4 million in 2025.
  • Business Quant data shows Assets Average for XFOR at $134.4 million in Q3 2025, $117.6 million in Q2 2025, and $138.2 million in Q1 2025.